Insider Selling: Team Health Holdings CFO Sells 40,000 Shares of Stock (TMH)
Team Health Holdings (NYSE:TMH) CFO David P. Jones sold 40,000 shares of the company’s stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $56.17, for a total value of $2,246,800.00. Following the completion of the sale, the chief financial officer now directly owns 77,590 shares in the company, valued at approximately $4,358,230. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Shares of Team Health Holdings (NYSE:TMH) traded up 0.86% on Thursday, hitting $56.41. 524,075 shares of the company’s stock traded hands. Team Health Holdings has a 1-year low of $36.41 and a 1-year high of $57.73. The stock’s 50-day moving average is $51.68 and its 200-day moving average is $47.78. The company has a market cap of $3.985 billion and a price-to-earnings ratio of 38.05.
Team Health Holdings (NYSE:TMH) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $0.61 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.53 by $0.08. The company had revenue of $675.10 million for the quarter, compared to the consensus estimate of $650.16 million. During the same quarter last year, the company posted $0.44 earnings per share. Team Health Holdings’s revenue was up 16.5% compared to the same quarter last year. On average, analysts predict that Team Health Holdings will post $2.30 earnings per share for the current fiscal year.
TMH has been the subject of a number of recent research reports. Analysts at Stifel Nicolaus upgraded shares of Team Health Holdings from a “hold” rating to a “buy” rating in a research note on Thursday. They now have a $63.00 price target on the stock, up previously from $57.00. Separately, analysts at Deutsche Bank upgraded shares of Team Health Holdings from a “hold” rating to a “buy” rating in a research note on Thursday. They now have a $57.00 price target on the stock, down previously from $63.00. Finally, analysts at Zacks upgraded shares of Team Health Holdings from a “neutral” rating to an “outperform” rating in a research note on Monday. They now have a $58.00 price target on the stock. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $61.00.
Team Health Holdings, Inc is a supplier of outsourced healthcare professional staffing and administrative services to hospitals and other healthcare providers in the United States, based upon revenues, patient visits, and number of clients.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.